We are live on ! Find out more
MLAB icon

Mesa Laboratories

123 hedge funds and large institutions have $656M invested in Mesa Laboratories in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 51 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 6

13% more funds holding

Funds holding: 109123 (+14)

7% more capital invested

Capital invested by funds: $614M → $656M (+$41.5M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

3.04% less ownership

Funds ownership: 76.6%73.56% (-3%)

33% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 51

Holders
123
Holders Change
+14
Holders Change %
+12.84%
% of All Funds
2.66%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
22
Increased
34
Reduced
51
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
51
Invesco
Georgia
$972K -$1.11M -4,920 -54%
YMRC
52
Yorktown Management & Research Company
Virginia
$958K
Citadel Advisors
53
Citadel Advisors
Florida
$916K +$275K +1,216 +44%
Marshall Wace
54
Marshall Wace
United Kingdom
$913K +$895K +3,961 New
Brown Advisory
55
Brown Advisory
Maryland
$893K -$56.1K -248 -6%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$876K +$113K +500 +15%
AllianceBernstein
57
AllianceBernstein
Tennessee
$848K
Envestnet Asset Management
58
Envestnet Asset Management
Illinois
$822K +$23.3K +103 +3%
First Trust Advisors
59
First Trust Advisors
Illinois
$567K +$556K +2,458 New
ACI
60
Alpha Cubed Investments
California
$558K -$2.49K -11 -0.5%
Victory Capital Management
61
Victory Capital Management
Texas
$526K -$22.6M -99,988 -98%
Barclays
62
Barclays
United Kingdom
$522K +$470K +2,078 +1,099%
AQR Capital Management
63
AQR Capital Management
Connecticut
$513K -$66K -292 -12%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$504K +$29.6K +131 +6%
GCP
65
GSA Capital Partners
United Kingdom
$496K +$486K +2,151 New
PP
66
Paloma Partners
Connecticut
$495K +$486K +2,148 New
AIG
67
American International Group
New York
$494K -$15.6K -69 -3%
Neuberger Berman Group
68
Neuberger Berman Group
New York
$474K -$49.7K -220 -10%
Cambridge Investment Research Advisors
69
Cambridge Investment Research Advisors
Iowa
$467K +$35.5K +157 +8%
MCM
70
Manchester Capital Management
Vermont
$461K
Truist Financial
71
Truist Financial
North Carolina
$403K -$54.2K -240 -12%
Goldman Sachs
72
Goldman Sachs
New York
$378K -$67.8K -300 -15%
ARTA
73
A.R.T. Advisors
New York
$373K -$68.9K -305 -16%
PNC Financial Services Group
74
PNC Financial Services Group
Pennsylvania
$373K +$44.5K +197 +14%
SIA
75
Sit Investment Associates
Minnesota
$369K

MLAB Hedge Fund Activity: Q1 2019 in Review

123 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2019, worth a combined $656M — up 6.8% from $614M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new MLAB positions and 6 closed out — a net gain of 16 holders — while 34 added to existing stakes and 51 trimmed.

The largest buyer was Martingale Asset Management, opening a new position worth an estimated $4.2M. The largest seller was Victory Capital Management, cutting an estimated $22.6M.

  • 123 institutional investors held Mesa Laboratories (MLAB) as of Q1 2019, up from 109 in Q4 2018.
  • Funds reported $656M of Mesa Laboratories stock for Q1 2019, up 6.8% quarter-over-quarter.
  • 22 funds opened new Mesa Laboratories positions in Q1 2019 and 6 closed out, a net change of +16 holders.
  • The largest Mesa Laboratories buyer in Q1 2019 was Martingale Asset Management, an estimated $4.2M added.
  • The largest Mesa Laboratories seller in Q1 2019 was Victory Capital Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2019.